AKT1 Protein (Protein Kinase B Alpha)

AKT1 Protein (Protein Kinase B Alpha)
Agent	Mechanism
**IGF-1**	Receptor-mediated PI3K activation
**Insulin (intranasal)**	InsR-mediated AKT1 activation
**GLP-1 agonists**	Indirect PI3K/AKT activation
**TrkB agonists**	BDNF receptor-mediated activation
Interactor	Type
**PIP3**	Activator
**PDK1**	Kinase
**mTORC2**	Kinase
**PTEN**	Phosphatase
**GSK-3β**	Substrate
**BAD**	Substrate
**FOXO3a**	Substrate
**TSC2**	Substrate
**PRAS40**	Substrate
Associated Diseases	ALS, Aging, Als, Alzheimer, Alzheimer's Disease
KG Connections	990 edges

Overview

AKT1 (Protein Kinase B alpha, PKBα) is a serine/threonine protein kinase that serves as a central hub in the PI3K/AKT/mTOR signaling pathway, one of the most critical survival and growth signaling cascades in neurons. As a member of the AKT kinase family (along with AKT2 and AKT3), AKT1 mediates cellular responses to growth factors, insulin, and other survival signals, playing essential roles in neuronal survival, synaptic plasticity, protein synthesis, and glucose metabolism^{1AKT/PKB signaling: navigating the network2017 · Cell · DOI 10.1016/j.cell.2017.04.001Open reference}.

In neurodegeneration, dysregulated AKT1 signaling has been implicated in Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), and amyotrophic lateral sclerosis (ALS), making it a key therapeutic target for neuroprotection^{2The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration2014 · Cell Signal · DOI 10.1016/j.cellsig.2014.08.019Open reference3Energy metabolism in adult neural stem cell fate2011 · Prog Neurobiol · DOI 10.1016/j.pneurobio.2010.10.007Open reference}.

Structure and Domain Architecture

AKT1 comprises 480 amino acids with three distinct domains:

1. PH Domain (Pleckstrin Homology, residues 1-106): Binds phosphatidylinositol (3,4,5)-trisphosphate (PIP3) and phosphatidylinositol (3,4)-bisphosphate (PIP2), mediating membrane recruitment upon PI3K activation. The PH domain contains the critical Arg25 residue that coordinates the phosphate groups of PIP3^{4Crystal structure of human AKT1 with PH domain2010 · PLoS One · DOI 10.1371/journal.pone.0012913Open reference}.

2. Kinase Domain (residues 150-408): Contains the activation loop with two essential phosphorylation sites:

   • Thr308: Phosphorylated by PDK1 (3-phosphoinositide-dependent protein kinase 1)

   • Ser473: Phosphorylated by mTORC2 (mTOR complex 2)

3. Regulatory Tail (residues 409-480): Contains the hydrophobic motif surrounding Ser473 and a proline-rich region.

Full activation of AKT1 requires dual phosphorylation at both Thr308 and Ser473, which induces a conformational change aligning the catalytic residues for substrate binding^{5Mechanism of activation of protein kinase B by insulin and IGF-11996 · EMBO J · PMID 8978681Open reference}.

Normal Function in Neurons

Survival Signaling

AKT1 promotes neuronal survival through multiple mechanisms:

• BAD Phosphorylation: AKT1 phosphorylates BAD at Ser136, preventing its interaction with anti-apoptotic BCL-2 and BCL-XL, thereby inhibiting the intrinsic apoptotic pathway^{6Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery1997 · Cell · DOI 10.1016/s0092-8674(00Open reference}.

• FOXO Inhibition: Phosphorylation of FOXO transcription factors (FOXO1, FOXO3a, FOXO4) promotes their nuclear export and degradation, suppressing pro-apoptotic gene expression^{7Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor1999 · Cell · DOI 10.1016/s0092-8674(00Open reference}.

• GSK-3β Inhibition: AKT1 phosphorylates GSK-3β at Ser9, inhibiting its kinase activity and preventing tau hyperphosphorylation, glycogen synthase activation, and β-catenin degradation^{8Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B1995 · Nature · DOI 10.1038/378785a0Open reference}.

Synaptic Plasticity

AKT1 regulates synaptic function through:

• mTORC1 Activation: Phosphorylation of TSC2 and PRAS40 releases inhibition of mTORC1, promoting protein synthesis required for long-term potentiation (LTP) and memory consolidation^{9mTOR signaling: at the crossroads of plasticity, memory and disease2010 · Trends Neurosci · DOI 10.1016/j.tins.2009.11.003Open reference}.

• CREB Signaling: AKT1 indirectly activates CREB through multiple pathways, supporting activity-dependent gene expression.

• GluR1 Trafficking: AKT1 modulates AMPA receptor trafficking, influencing synaptic strength^{10Akt phosphorylates GluR1-containing AMPA receptors2020 · J Neurochem · DOI 10.1111/jnc.14983Open reference}.

Metabolic Regulation

AKT1 mediates insulin signaling in the brain:

• Glucose Uptake: Promotes GLUT4 translocation in insulin-responsive neurons

• Glycogen Synthesis: Activates glycogen synthase via GSK-3β inhibition

• Protein Synthesis: Activates mTORC1-dependent translation

Role in Neurodegeneration

Alzheimer’s Disease

AKT1 dysfunction is central to AD pathogenesis:

1. Insulin Resistance: Brain insulin resistance in AD correlates with reduced AKT1 activation. Postmortem AD brains show decreased phospho-AKT (Ser473) levels in hippocampus and cortex^{2The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration2014 · Cell Signal · DOI 10.1016/j.cellsig.2014.08.019Open reference}0.

2. GSK-3β Dysregulation: Impaired AKT1-mediated GSK-3β inhibition contributes to tau hyperphosphorylation. GSK-3β is constitutively active and phosphorylates tau at multiple AD-relevant sites (Ser202, Thr231, Ser396/404)^{2The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration2014 · Cell Signal · DOI 10.1016/j.cellsig.2014.08.019Open reference}1.

3. Amyloid-β Effects: Aβ oligomers can inhibit PI3K/AKT signaling by activating PTEN or inducing insulin resistance, creating a feed-forward loop promoting neurodegeneration^{2The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration2014 · Cell Signal · DOI 10.1016/j.cellsig.2014.08.019Open reference}2.

4. ApoE4 Interaction: ApoE4 carriers show reduced AKT1 activation, potentially explaining increased AD susceptibility^{2The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration2014 · Cell Signal · DOI 10.1016/j.cellsig.2014.08.019Open reference}3.

Parkinson’s Disease

AKT1 neuroprotection in PD involves:

1. Dopaminergic Neuron Survival: AKT1 activation protects substantia nigra neurons from oxidative stress and mitochondrial dysfunction^{2The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration2014 · Cell Signal · DOI 10.1016/j.cellsig.2014.08.019Open reference}4.

2. α-Synuclein Toxicity: AKT1 activation attenuates α-synuclein-induced neurotoxicity through enhanced autophagy and reduced ER stress^{2The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration2014 · Cell Signal · DOI 10.1016/j.cellsig.2014.08.019Open reference}5.

3. LRRK2 Interaction: Mutant LRRK2 can phosphorylate and activate AKT1, but chronic activation may contribute to dysregulated signaling in PD^{2The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration2014 · Cell Signal · DOI 10.1016/j.cellsig.2014.08.019Open reference}6.

4. DJ-1/PARK7: The PD-associated protein DJ-1 activates AKT1, and loss of DJ-1 function reduces AKT1-mediated neuroprotection^{2The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration2014 · Cell Signal · DOI 10.1016/j.cellsig.2014.08.019Open reference}7.

Huntington’s Disease

In HD, AKT1 plays complex roles:

1. mHTT Toxicity: Mutant huntingtin interferes with AKT1 activation, contributing to neuronal vulnerability^{2The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration2014 · Cell Signal · DOI 10.1016/j.cellsig.2014.08.019Open reference}8.

2. Transcriptional Dysregulation: Impaired AKT1 signaling contributes to dysregulated CREB-dependent gene expression in HD.

3. Therapeutic Activation: Pharmacological AKT1 activation provides neuroprotection in HD models^{2The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration2014 · Cell Signal · DOI 10.1016/j.cellsig.2014.08.019Open reference}9.

Amyotrophic Lateral Sclerosis

AKT1 involvement in ALS includes:

1. Motor Neuron Survival: AKT1 activation promotes motor neuron survival through enhanced autophagy and reduced apoptosis^{3Energy metabolism in adult neural stem cell fate2011 · Prog Neurobiol · DOI 10.1016/j.pneurobio.2010.10.007Open reference}0.

2. SOD1 Mutations: Mutant SOD1 interferes with AKT1 signaling, contributing to motor neuron degeneration.

3. TDP-43 Pathology: AKT1 activation can reduce TDP-43 aggregation and toxicity^{3Energy metabolism in adult neural stem cell fate2011 · Prog Neurobiol · DOI 10.1016/j.pneurobio.2010.10.007Open reference}1.

Therapeutic Targeting

AKT1 Activators

Upstream Targets

1. PI3K Inhibitors/Activators: While PI3K inhibitors (e.g., buparlisib) are used in cancer, PI3K activation may be neuroprotective^{3Energy metabolism in adult neural stem cell fate2011 · Prog Neurobiol · DOI 10.1016/j.pneurobio.2010.10.007Open reference}2.

2. PTEN Inhibitors: PTEN negatively regulates AKT1; selective inhibition could boost survival signaling.

3. PDK1 Modulators: Targeting PDK1 could selectively enhance AKT1 Thr308 phosphorylation^{3Energy metabolism in adult neural stem cell fate2011 · Prog Neurobiol · DOI 10.1016/j.pneurobio.2010.10.007Open reference}3.

Downstream Targets

1. GSK-3β Inhibitors: Tideglusib and lithium inhibit GSK-3β, mimicking AKT1 activation^{3Energy metabolism in adult neural stem cell fate2011 · Prog Neurobiol · DOI 10.1016/j.pneurobio.2010.10.007Open reference}4.

2. mTOR Modulators: Rapamycin analogs affect mTORC1, downstream of AKT1.

Challenges

• Cancer Risk: Chronic AKT1 activation promotes cell proliferation; long-term activation increases cancer risk^{3Energy metabolism in adult neural stem cell fate2011 · Prog Neurobiol · DOI 10.1016/j.pneurobio.2010.10.007Open reference}5.

• Isoform Specificity: AKT1 vs AKT2 vs AKT3 have distinct functions; selective modulation is preferred.

• Blood-Brain Barrier: Many AKT-targeting compounds have poor CNS penetration.

Key Interactions

See Also

• PI3K/AKT Pathway

• GSK-3β

• PTEN

• mTOR

• Tau Protein

• Insulin Signaling